Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
Nuwellis, Inc., a medical technology firm focused on cardiorenal solutions, reported a 14% increase in net sales for Q2 2026 over the prior year, driven by increased U.S. revenue and console sales. The company improved its gross margin to 76% and raised approximately $12.7 million in gross proceeds through recent financings and warrant exercises, e…